Low plasma refers to a shortfall in either the fluid portion of your blood (plasma volume) or the proteins dissolved in it, and it affects everything from blood pressure regulation to wound healing and immune defense. Plasma makes up roughly 55 percent of your total blood volume, so even a moderate drop can trigger a cascade of symptoms ranging from lightheadedness to organ damage. The causes span from something as simple as not drinking enough water to serious conditions like liver failure or massive burns, and treatment depends entirely on which component is low and why.
What “Low Plasma” Means in Practice
Plasma is the pale-yellow liquid that carries red blood cells, white blood cells, and platelets through your circulatory system. It is mostly water, but it also contains dissolved proteins (albumin, clotting factors, immunoglobulins), electrolytes, hormones, and waste products. When people talk about “low plasma,” they could mean one of two related but distinct problems. The first is low plasma volume, sometimes called hypovolemia, where the total amount of fluid in the bloodstream drops. The second is low plasma protein levels, particularly low albumin, which changes how fluid behaves inside and outside your blood vessels.
These two problems often travel together, but not always. You can have low plasma volume with normal protein concentrations if you lose whole blood quickly, or you can have normal total volume but dangerously low albumin from chronic liver disease. The distinction matters because treatment for one can be wrong or useless for the other.
Why Plasma Volume Drops
Your body maintains plasma volume through a tightly regulated feedback loop. When sensors in the kidneys and blood vessels detect a dip in circulating volume, the renin-angiotensin-aldosterone system kicks in, prompting the kidneys to hold onto sodium and water to rebuild fluid levels.1PubMed. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies That system works well for mild, slow losses. But when fluid leaves the bloodstream faster than the kidneys can compensate, plasma volume falls and problems start.
The most common triggers fall into a few broad categories:
- Dehydration: Inadequate fluid intake, excessive sweating, prolonged vomiting, or severe diarrhea all reduce the water available for plasma. In developing countries, massive gastrointestinal fluid loss remains a leading cause of hypovolemia severe enough to cause acute kidney injury.2PubMed Central. Novel cause of Acute Kidney Injury and its Predictors of Mortality
- Hemorrhage: Obvious or internal bleeding directly removes plasma along with blood cells. Trauma, surgery, and gastrointestinal bleeds are common culprits.
- Capillary leak: In conditions like systemic capillary leak syndrome, severe infections, or ovarian hyperstimulation syndrome, the walls of small blood vessels become abnormally permeable. Protein-rich fluid escapes into surrounding tissues, leaving the bloodstream depleted even though the fluid hasn’t left the body. In the most severe cases, this can progress to hypovolemic shock.3Kidney International. Capillary leak syndrome: etiologies, pathophysiology, and management
- Burns: Damaged skin and underlying tissue lose the ability to keep fluid contained, and large burns can shift enormous volumes of plasma into injured tissue within hours.
In each of these scenarios, the body’s compensatory hormones fire up. Renin, aldosterone, and vasopressin all rise, pushing the kidneys to retain whatever fluid they can.4PubMed. Fluid-regulating hormones and plasma volume during 60 days of head-down bed rest with exercise during artificial gravity (BRACE) That hormonal response explains why you may notice concentrated, dark urine and intense thirst before other symptoms appear: your kidneys are already working overtime to conserve water.
Why Plasma Proteins Drop
Albumin is the single most abundant protein in plasma, and its levels serve as a rough barometer of plasma protein status overall. Low albumin (hypoalbuminemia) has three main causes: the liver isn’t making enough, the kidneys or gut are losing too much, or inflammation is driving levels down independently of nutrition.
Chronic liver disease is the textbook example of inadequate production. The liver is the sole manufacturing site for albumin, and as liver function deteriorates, output falls. In patients with advanced chronic liver failure, albumin synthesis rates have been measured as low as about 65 milligrams per kilogram per day on average, with some individuals producing as little as 32, and these low rates correlate with worsening liver-function scores.5PubMed. Albumin and fibrinogen synthesis rates in advanced chronic liver disease The same study found that fibrinogen, a clotting protein also made by the liver, declined in parallel.
On the loss side, nephrotic syndrome is the classic offender. Damaged kidney filters allow intermediate-sized proteins like albumin, transferrin, and immunoglobulin G to spill into the urine, steadily draining the plasma of proteins it cannot quickly replace.6PubMed. Plasma composition in the nephrotic syndrome Protein-losing enteropathy does the same thing through the gut wall. And severe malnutrition reduces the amino acid building blocks the liver needs to synthesize new protein.
There is a common misconception worth noting here. Low albumin is often assumed to mean poor nutrition, and it can. But inflammatory conditions, infections, and certain medications also suppress albumin levels, and these non-nutritional causes likely account for the majority of low readings in hospital settings.7PubMed. Low levels of plasma proteins: malnutrition or inflammation? Using albumin alone to diagnose malnutrition is unreliable because inflammation muddles the picture.
Recognizing the Symptoms
The symptoms of low plasma depend on how quickly the deficit develops and which component is affected. A slow, gradual decline may go unnoticed until it is quite advanced, while an acute drop from hemorrhage or severe dehydration announces itself within minutes.
Low plasma volume typically shows up first as cardiovascular strain. Your heart has less fluid to pump, so it compensates by beating faster. When you stand up, gravity pools blood in your legs and there isn’t enough volume to keep your brain adequately perfused. The result is orthostatic intolerance: dizziness, lightheadedness, nausea, palpitations, or even fainting upon standing. In more formal terms, the standing position can trigger either a measurable drop in blood pressure (orthostatic hypotension) or an excessive rise in heart rate (postural orthostatic tachycardia syndrome), both of which share that same constellation of unpleasant symptoms.8ESC CardioMed. Orthostatic intolerance: orthostatic hypotension and postural orthostatic tachycardia syndrome
Other signs of plasma volume depletion include dry mouth, reduced urine output, sunken eyes, poor skin turgor (when you pinch the skin on the back of your hand and it stays tented instead of snapping back), and in severe cases, confusion or altered consciousness. These are signs of circulatory compromise, meaning critical organs are not getting the blood flow they need.
Low plasma proteins cause a somewhat different pattern. When albumin drops, the oncotic pressure that normally holds fluid inside blood vessels weakens. Fluid seeps out into tissues, causing edema, the puffy swelling most visible in the ankles, feet, and around the eyes. Paradoxically, you can be edematous and volume-depleted at the same time: there is plenty of fluid in the body, but it’s in the wrong compartment. Capillary leak syndrome is the extreme version of this phenomenon, where protein-rich fluid floods the tissues while the bloodstream empties out.3Kidney International. Capillary leak syndrome: etiologies, pathophysiology, and management
Loss of other plasma proteins brings its own problems. Low clotting factors mean easy bruising and prolonged bleeding. Low immunoglobulins increase vulnerability to infections. Low transferrin impairs iron transport, contributing to anemia.
How Doctors Figure Out What’s Going On
Diagnosing low plasma is rarely about a single lab test. Clinicians piece together the picture from physical examination, vital signs, and a handful of blood and urine tests.
Hematocrit, the percentage of blood made up of red blood cells, offers indirect evidence. When plasma volume drops but red blood cell numbers stay the same, the blood becomes more concentrated, and hematocrit rises. This hemoconcentration can serve as a real-time indicator of how severe the plasma loss is, particularly in conditions like capillary leak syndrome where it tends to spike quickly.3Kidney International. Capillary leak syndrome: etiologies, pathophysiology, and management The reverse is also informative: a falling hematocrit alongside clinical signs of hemorrhage suggests whole-blood loss rather than plasma-specific depletion.
Serum albumin is the primary marker for plasma protein status, though as mentioned earlier, it must be interpreted cautiously because inflammation drives it down independently of nutrition.7PubMed. Low levels of plasma proteins: malnutrition or inflammation? Other proteins like transferrin and prealbumin (transthyretin) are sometimes measured alongside albumin, but they share the same limitation. A low albumin in a patient with active infection or recent surgery may reflect the inflammatory response, not inadequate intake. Physicians look for additional context: dietary history, liver function tests, urinary protein excretion, and markers of inflammation like C-reactive protein.
Beyond lab work, clinical assessment remains essential. Blood pressure measurements taken both lying down and standing can reveal orthostatic changes. Urine output tracking, assessment of mucous membranes, capillary refill time, and mental status all help grade the severity. In critical care settings, more invasive monitoring of central venous pressure or cardiac output may be used to guide treatment in real time.
Treatment for Acute Plasma Volume Loss
When someone is acutely volume-depleted, the immediate priority is replacing fluid in the bloodstream. The two broad categories of intravenous fluids are crystalloids (salt-water solutions like normal saline or lactated Ringer’s) and colloids (solutions containing larger molecules like albumin, gelatin, or synthetic starches that stay in the bloodstream longer).
For decades there was debate over whether colloids offered a survival advantage, since their larger molecules should theoretically expand plasma volume more efficiently. The evidence has largely settled this. A major Cochrane review found that using colloids versus crystalloids probably makes little or no difference to mortality in critically ill patients.9PubMed Central. Colloids versus crystalloids for fluid resuscitation in critically ill patients Synthetic starches, in particular, slightly increase the need for kidney-replacement therapy. One large randomized trial (the CRISTAL trial) did find a small mortality difference favoring colloids at 90 days, with about 31 percent dying in the colloids group versus about 34 percent in the crystalloids group, but the 28-day mortality difference was not statistically significant.10JAMA. Effects of Fluid Resuscitation With Colloids vs Crystalloids on Mortality in Critically Ill Patients Presenting With Hypovolemic Shock: The CRISTAL Randomized Trial
In practice, most emergency and critical care settings start with crystalloids because they are cheap, widely available, and safe. Colloids get reserved for specific situations. Albumin infusion, for example, has shown value in patients with low albumin who are in septic shock: it stabilizes blood pressure during resuscitation, helps overcome resistance to diuretics, and may improve survival in that specific subgroup.11PubMed Central. Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years
Treating Low Clotting Factors With Plasma Products
When the problem is not fluid volume but depleted clotting proteins, treatment shifts to plasma-derived products. Fresh frozen plasma (FFP) contains the full spectrum of clotting factors and is used to correct coagulopathy, the medical term for blood that does not clot properly. This is common in liver failure, massive transfusion after trauma, or warfarin overdose.
A recent prospective study showed that FFP transfusion significantly improved clotting times: the average measure of clotting speed (INR) dropped from about 3.15 before transfusion to about 1.96 afterward. Adding supplementary agents like vitamin K or prothrombin complex concentrate (PCC) to FFP enhanced the correction further, with PCC-plus-FFP producing the greatest improvement.12PubMed Central. Audit and Evaluation of the Effect of Fresh Frozen Plasma and Adjunct Pharmacological Agents (Vitamin K1, Prothrombin Complex Concentrate, Tranexamic Acid, and Recombinant Factor VIIa) on Pre- and Post- Transfusion INR in Patients with Coagulopathy This tells us that plasma replacement for clotting deficiencies works, but a combination approach tends to work better than FFP alone.
Nutritional Strategies for Low Albumin
Not every case of low plasma protein calls for intravenous albumin. When the underlying problem is chronic malnutrition or protein-calorie deficiency, the more sustainable fix is dietary. Your liver needs a steady supply of amino acids to produce albumin, and boosting protein intake can raise endogenous synthesis over time.
High-protein nutritional formulations, particularly those based on egg-white protein, have shown promise in hospitalized patients with low albumin. Egg-white proteins offer a complete essential amino acid profile and are well absorbed, and clinical evaluations of specialized albumin-support formulas have shown improvements in both serum albumin levels and gastrointestinal tolerance.13International Journal Of Community Medicine And Public Health. High-protein albumin-based nutritional support in severe hypoalbuminemia: a narrative review of ALBUCURE efficacy, tolerability, and clinical outcomes For patients who can eat, this approach avoids the costs and risks of repeated intravenous infusions.
That said, nutritional support works slowly. It takes days to weeks for dietary protein to translate into measurably higher albumin in the bloodstream. In patients with active inflammation, nutritional improvements may not move the albumin needle at all until the inflammatory trigger is addressed. This is one reason why a combined strategy, treating the underlying disease while optimizing nutrition, tends to outperform either approach alone.
Low Plasma in Spaceflight
One of the more fascinating settings in which low plasma occurs is microgravity. Astronauts consistently experience plasma volume contraction within the first hours to days of spaceflight, typically losing about 10 percent of their plasma volume.14PubMed Central. The effect of mild decrement in plasma volume simulating short-duration spaceflight on intracranial pressure
The mechanism is unlike anything seen in typical dehydration. On Earth, gravity pulls blood and fluid toward the lower body. In microgravity, that gravitational pooling disappears, and fluid redistributes toward the head and chest. The body interprets this upper-body fluid shift as a sign of excess volume and responds by reducing fluid intake and allowing plasma to filter out of blood vessels into upper-body tissues.15PubMed. Plasma and blood volume in space Reduced muscle tone in microgravity also plays a role, since muscles that are no longer working to maintain posture stop acting as a fluid reservoir.16PubMed. Fluid volume control during short-term space flight and implications for human performance
The result is astronauts with puffy faces, thin legs, and a contracted plasma volume that closely resembles mild hypovolemia. Upon return to Earth, this becomes a real problem: the reduced blood volume makes it harder to tolerate the sudden re-imposition of gravity, and many astronauts feel lightheaded or faint when they first stand up. Research into countermeasures, including exercise protocols and artificial gravity during long-duration missions, has shown that the body’s hormonal responses (renin and aldosterone release) can be triggered even in space, but preventing the plasma volume drop entirely has remained elusive.4PubMed. Fluid-regulating hormones and plasma volume during 60 days of head-down bed rest with exercise during artificial gravity (BRACE)
When Low Plasma Volume Is Engineered on Purpose
Not all plasma removal is accidental or pathological. Therapeutic plasma exchange, or plasmapheresis, deliberately removes a patient’s plasma and replaces it with donor plasma or albumin solution. The concept goes back surprisingly far: experimental animal work on the principle dates to 1902, and the technique was first used in humans in 1909.17Archives of Internal Medicine. Therapeutic Plasma Exchange
Modern plasmapheresis is used to treat autoimmune conditions and blood disorders where the problem is something harmful dissolved in the plasma itself, such as pathological antibodies in myasthenia gravis or Guillain-Barré syndrome, or excess proteins in certain blood cancers. The goal is to strip out the offending molecules while returning blood cells and replacement fluid to the patient. Contemporary devices have greatly improved the safety of the procedure through real-time monitoring, automatic pressure alarms, and minimized extracorporeal blood volumes, meaning less of the patient’s blood sits outside their body at any given moment during the exchange.18Transfusion and Apheresis Science. History of therapeutic apheresis
Patients undergoing plasmapheresis do temporarily have low plasma volume and depleted plasma proteins, which is why replacement fluid, usually albumin, is infused at the same time. The transient depletion is a calculated trade-off, and the side effects (lightheadedness, tingling from citrate anticoagulant, mild drops in blood pressure) mirror the symptoms of other causes of low plasma. Most resolve within hours as the body rebuilds its protein and fluid levels.
Edema, Volume Depletion, and the Paradox of Being Both at Once
One of the most confusing aspects of low plasma for patients and even some clinicians is that you can appear swollen and still be volume-depleted. This happens in nephrotic syndrome, liver cirrhosis, and capillary leak states. The kidneys detect low circulating volume and retain sodium and water, but because albumin is too low to hold fluid inside the blood vessels, the retained fluid immediately leaks into tissues, worsening the edema without fixing the volume deficit.3Kidney International. Capillary leak syndrome: etiologies, pathophysiology, and management
This is why simply giving more saline to a patient with severe hypoalbuminemia can backfire spectacularly. The salt water enters the bloodstream, but with little albumin to hold it there, it filters right out into the tissues. Ankles swell further, fluid may accumulate around the lungs, and the patient feels worse even though their blood volume hasn’t meaningfully improved. In these situations, albumin infusion alongside or before diuretics can break the cycle: the albumin raises oncotic pressure, pulls fluid back into the bloodstream, and then the diuretic can remove the excess through the kidneys.11PubMed Central. Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years Understanding this paradox matters because the instinct to give fluids for volume depletion, normally the right move, needs to be tempered by awareness of the protein status driving the fluid maldistribution.